Evidence map›Paper›PMID 22968041›Full record

ArticleBiochemical pharmacology2012

Thiocyanate: a potentially useful therapeutic agent with host defense and antioxidant properties.

Joshua D Chandler, Brian J Day

Open access · greenAbstract read
In one paragraph

Article in Biochemical pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 170 citations in OpenAlex.

  1. Pooled it
  2. Caustic Ingestion With Potassium Thiocyanate.ACG case reports journal · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Lactoperoxidase: Properties, Functions, and Potential Applications.International journal of molecular sciences · 2025
    Review
  10. Exploring Anti-inflammatory Compounds fromAnti-inflammatory & anti-allergy agents in medicinal chemistry · 2025
    Article
  11. Observational
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Joshua D ChandlerDepartment of Medicine, National Jewish Health, Denver, CO 80206, United States.
Brian J Day
National Jewish Health · USUniversity of Colorado Denver · US

Funding

Adaptive glutathione responses to cigarette smoke in COPDR01HL084469 · NHLBI · NATIONAL JEWISH HEALTH · PI DAY, BRIAN J · 2008 to 2011
$1.6M
Glutathione transport, oxidative stress and lung injuryR01HL075523 · NHLBI · NATIONAL JEWISH HEALTH · PI DAY, BRIAN J · 2004 to 2007
$1.3M
NHLBI NIH HHS HL084469NHLBI NIH HHS R01 HL075523NHLBI NIH HHS R01 HL084469
6 · The paper itself

Abstract

Thiocyanate (SCN) functions in host defense as part of the secreted lactoperoxidase (LPO) microbicidal pathway. SCN is the preferred substrate for LPO-driven catalytic reduction of hydrogen peroxide (H(2)O(2)) forming hypothiocyanous acid (HOSCN). HOSCN is selectively generated by many peroxidase enzymes that can utilize SCN including: eosinophil peroxidase (EPO), gastric peroxidase (GPO), myeloperoxidase (MPO), salivary peroxidase (SPO), and thyroid peroxidase (TPO). These enzymes generate HOSCN through a two-electron halogenation reaction. HOSCN is a potent microbicidal agent that kills or nullifies invading pathogens but is better tolerated by host tissue. Some controversy exists as to whether physiologic levels of HOSCN are non-toxic to host tissue, but the disagreement appears to be based on results of enzymatic generation (yielding moderate steady-state exposure) versus direct high level acute exposure in mammalian cell lines. This apparent duality is also true of other endogenous oxidants such as hydrogen peroxide and relates to the difference between physiologically relevant oxidant production versus supra-physiologic bolus dosing approaches. SCN has antioxidant properties that include the ability to protect cells against oxidizing agents such as hypochlorous acid (HOCl) and repair protein chloramines. SCN is an important endogenous molecule that has the potential to interact in complex and elegant ways with its host environment and foreign organisms. SCN's diverse properties as both host defense and antioxidant agent make it a potentially useful therapeutic.

Indexed as

AnimalsAntioxidantsHumansHypertensionThiocyanatesAntioxidantsThiocyanates

Identifiers

PMID22968041
PMCPMC3983948
OpenAlexW2075288834

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.